Harvard Apparatus Regenerative Technology HRGN Insider Ownership

Updated Nov 4, 2026

Over the trailing 12 months, HRGN insiders bought $399,559 worth of shares (371.63K shares) in open-market trades, with no open-market sales.

• Among Harvard Apparatus Regenerative Technology insiders, Junli He (CEO) led open-market buying over the past 12 months with $399,559 of purchases (371.63K shares); the latest was on September 15, 2026.
• Apart from open-market trades, HRGN insiders acquired 683.73K shares through option exercises and conversions in the past 12 months.
• Per Business Quant, HRGN insiders together hold 1.68Mn shares based on their latest Form 4 filings, or 9.54% of the 17.58Mn shares outstanding.
• HRGN's insiders hold all 1.68Mn shares directly, in their own names, with no indirect holdings.
• HRGN's insider total is spread across 4 insiders who have filed a Form 4 in the past two years.
• HRGN's three largest insider shareholders, per their latest Form 4 filings, are Junli He (CEO, 1.33Mn shares), Jing Chen (Director, 161.47K shares) and David Green (Director and officer, 158.86K shares).
• Junli He alone accounts for 79.48% of the shares held by Harvard Apparatus Regenerative Technology insiders.
• A total of 3 Form 4 filings with transactions in Harvard Apparatus Regenerative Technology stock were made over the past 12 months, by one insider.
• The insider holdings and trades above for Harvard Apparatus Regenerative Technology reflect Form 4 filings through September 25, 2026.